These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 35923707)

  • 1. Molecular Genetic Screening in Patients With ACE Inhibitor/Angiotensin Receptor Blocker-Induced Angioedema to Explore the Role of Hereditary Angioedema Genes.
    Mathey CM; Maj C; Scheer AB; Fazaal J; Wedi B; Wieczorek D; Amann PM; Löffler H; Koch L; Schöffl C; Dickel H; Ganjuur N; Hornung T; Forkel S; Greve J; Wurpts G; Hallberg P; Bygum A; Von Buchwald C; Karawajczyk M; Steffens M; Stingl J; Hoffmann P; Heilmann-Heimbach S; Mangold E; Ludwig KU; Rasmussen ER; Wadelius M; Sachs B; Nöthen MM; Forstner AJ
    Front Genet; 2022; 13():914376. PubMed ID: 35923707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exome Sequencing Reveals Common and Rare Variants in F5 Associated With ACE Inhibitor and Angiotensin Receptor Blocker-Induced Angioedema.
    Maroteau C; Siddiqui MK; Veluchamy A; Carr F; White M; Cassidy AJ; Baranova EV; Rasmussen ER; Eriksson N; Bloch KM; Brown NJ; Bygum A; Hallberg P; Karawajczyk M; Magnusson PKE; Yue QY; Syvänen AC; von Buchwald C; Alfirevic A; Maitland-van der Zee AH; Wadelius M; Palmer CNA;
    Clin Pharmacol Ther; 2020 Dec; 108(6):1195-1202. PubMed ID: 32496628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide association study of angioedema induced by angiotensin-converting enzyme inhibitor and angiotensin receptor blocker treatment.
    Rasmussen ER; Hallberg P; Baranova EV; Eriksson N; Karawajczyk M; Johansson C; Cavalli M; Maroteau C; Veluchamy A; Islander G; Hugosson S; Terreehorst I; Asselbergs FW; Norling P; Johansson HE; Kohnke H; Syvänen AC; Siddiqui MK; Lang CC; Magnusson PKE; Yue QY; Wadelius C; von Buchwald C; Bygum A; Alfirevic A; Maitland-van der Zee AH; Palmer CNA; Wadelius M
    Pharmacogenomics J; 2020 Dec; 20(6):770-783. PubMed ID: 32080354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Over diagnosis of bradykinin angioedema in patients treated with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers.
    Douillard M; Deheb Z; Bozon A; Raison-Peyron N; Dereure O; Moulis L; Soria A; Du-Thanh A
    World Allergy Organ J; 2023 Aug; 16(8):100809. PubMed ID: 37638360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of Bradykinin Formation and Degradation in Blood Plasma: Relevance for Acquired Angioedema Associated With Angiotensin Converting Enzyme Inhibition and for Hereditary Angioedema Due to Factor XII or Plasminogen Gene Variants.
    Marceau F; Rivard GE; Gauthier JM; Binkley KE; Bonnefoy A; Boccon-Gibod I; Bouillet L; Picard M; Levesque G; Elfassy HL; Bachelard H; Hébert J; Bork K
    Front Med (Lausanne); 2020; 7():358. PubMed ID: 32766265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-analysis of ACE inhibitor-induced angioedema identifies novel risk locus.
    Mathey CM; Maj C; Eriksson N; Krebs K; Westmeier J; David FS; Koromina M; Scheer AB; Szabo N; Wedi B; Wieczorek D; Amann PM; Löffler H; Koch L; Schöffl C; Dickel H; Ganjuur N; Hornung T; Buhl T; Greve J; Wurpts G; Aygören-Pürsün E; Steffens M; Herms S; Heilmann-Heimbach S; Hoffmann P; Schmidt B; Mavarani L; Andresen T; Sørensen SB; Andersen V; Vogel U; Landén M; Bulik CM; ; ; Bygum A; Magnusson PKE; von Buchwald C; Hallberg P; Rye Ostrowski S; Sørensen E; Pedersen OB; Ullum H; Erikstrup C; Bundgaard H; Milani L; Rasmussen ER; Wadelius M; Ghouse J; Sachs B; Nöthen MM; Forstner AJ
    J Allergy Clin Immunol; 2024 Apr; 153(4):1073-1082. PubMed ID: 38300190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutant plasminogen in hereditary angioedema is bypassing FXII/kallikrein to generate bradykinin.
    Hintze S; Möhl BS; Beyerl J; Wulff K; Wieser A; Bork K; Meinke P
    Front Physiol; 2022; 13():1090732. PubMed ID: 36685169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Genetics of Hereditary Angioedema: A Review.
    Santacroce R; D'Andrea G; Maffione AB; Margaglione M; d'Apolito M
    J Clin Med; 2021 May; 10(9):. PubMed ID: 34065094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin-Converting Enzyme Inhibitor-Associated Angioedema: From Bed to Bench.
    Carucci L; Bova M; Petraroli A; Ferrara AL; Sutic A; de Crescenzo G; Cordisco G; Margaglione M; Gambardella J; Spadaro G; Genovese A; Loffredo S
    J Investig Allergol Clin Immunol; 2020; 30(4):272-280. PubMed ID: 31599724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology of Bradykinin-mediated angioedema: a systematic investigation of epidemiological studies.
    Aygören-Pürsün E; Magerl M; Maetzel A; Maurer M
    Orphanet J Rare Dis; 2018 May; 13(1):73. PubMed ID: 29728119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survey of actual conditions of erythema marginatum as a prodromal symptom in Japanese patients with hereditary angioedema.
    Ohsawa I; Fukunaga A; Imamura S; Iwamoto K; Tanaka A; Hide M; Honda D; Yamashita K; Fujiwara C; Ishikawa O; Yamaguchi T; Maehara J; Hirose T; Ieko M; Umekita K; Nakamura Y; Gotoh H
    World Allergy Organ J; 2021 Feb; 14(2):100511. PubMed ID: 33643518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deciphering the Genetics of Primary Angioedema with Normal Levels of C1 Inhibitor.
    Loules G; Parsopoulou F; Zamanakou M; Csuka D; Bova M; González-Quevedo T; Psarros F; Porebski G; Speletas M; Firinu D; Del Giacco S; Suffritti C; Makris M; Vatsiou S; Zanichelli A; Farkas H; Germenis AE
    J Clin Med; 2020 Oct; 9(11):. PubMed ID: 33114181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of ace gene polymorphism in the development of angioedema secondary to angiotensin converting enzyme inhibitors and angiotensin II receptor blockers.
    Gulec M; Caliskaner Z; Tunca Y; Ozturk S; Bozoglu E; Gul D; Erel F; Kartal O; Karaayvaz M
    Allergol Immunopathol (Madr); 2008; 36(3):134-40. PubMed ID: 18680700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenetics of angiotensin-converting enzyme inhibitor-induced angioedema.
    Liau Y; Chua I; Kennedy MA; Maggo S
    Clin Exp Allergy; 2019 Feb; 49(2):142-154. PubMed ID: 30537422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin-converting enzyme inhibitor-induced angioedema: A review of the literature.
    Brown T; Gonzalez J; Monteleone C
    J Clin Hypertens (Greenwich); 2017 Dec; 19(12):1377-1382. PubMed ID: 28994183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and treatment of bradykinin-mediated angioedema: outcomes from an angioedema expert consensus meeting.
    Craig TJ; Bernstein JA; Farkas H; Bouillet L; Boccon-Gibod I
    Int Arch Allergy Immunol; 2014; 165(2):119-27. PubMed ID: 25401373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of losartan induced angioedema.
    Nair C
    Indian J Med Sci; 2010 Feb; 64(2):81-4. PubMed ID: 22466497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and tolerability of angiotensin-converting enzyme inhibitor versus the combination of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker in patients with left ventricular dysfunction: a systematic review and meta-analysis of randomized controlled trials.
    Lakhdar R; Al-Mallah MH; Lanfear DE
    J Card Fail; 2008 Apr; 14(3):181-8. PubMed ID: 18381180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-induced visceral angioedema.
    Thalanayar PM; Ghobrial I; Lubin F; Karnik R; Bhasin R
    J Community Hosp Intern Med Perspect; 2014; 4(4):. PubMed ID: 25317271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An update on the genetics and pathogenesis of hereditary angioedema.
    Banday AZ; Kaur A; Jindal AK; Rawat A; Singh S
    Genes Dis; 2020 Mar; 7(1):75-83. PubMed ID: 32181278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.